Avicenna Hospital Lahore
Lahore, Punjab Province, 54000, Pakistan
NCT Number: NCT07150065
Sample size of 360 children with typhoid fever were enrolled and randomly divided in two groups. All the children were enrolled in the trial from Pediatrics emergency. Informed consent was obtained from parents. Demographics (name, age of child, sex of the child, duration of fever, weight, season, socioeconomic status and residence) were noted. Then children were admitted and randomly divided in two groups by using lottery method. In group A, children were given oral 200 mg levofloxacin tablet. In group B, children were given oral 900-1,000 mg ciprofloxacin tablet. All children were followed-up pediatric wards for 7 days. If fever was resolved within 5 days (body temperature falls <99oF and remain stable for at least 5 days), then efficacy was labeled. Total time required to resolve fever i.e. body temperature <99oF in all children was also noted. All this information was recorded
Looking for future studies?
Notify Me1 year–12 year
All sexes
Interventional
Phase 2
Lahore, Punjab Province, 54000, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral 200 mg levofloxacin tablet
Oral 900-1,000 mg ciprofloxacin tablet
Time frame: 5 days
Clinical efficacy involved resolution of fever within 5 days (body temperature falls <99oF and remain stable for at least 5 days). Total time required to resolve fever i.e. body temperature <99oF in all children was also noted.
Avicenna Medical College Lahore
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04878549
Acute Febrile Illness, Bacterial Infections
Vellore, India
View Trial DetailsNCT07624175
Bacterial Infections, Bacterial Infections and Mycoses
Ouagadougou, Burkina Faso
View Trial DetailsNCT03614533
Bacterial Infections, Bacterial Infections and Mycoses
Ouagadougou, Burkina Faso
View Trial DetailsNCT05475379
Bacterial Infections, Bacterial Infections and Mycoses
Dhaka, Bangladesh
View Trial Details